target

Glaxosmithkline Consumer Healthcare Holdings

bidder

Glaxosmithkline

£9,180m

45 dealmakers

target

XIIDRA

bidder

Novartis

£4,066m

52 dealmakers

target

Alcon

bidder

Institutional Investors

£20,634m

92 dealmakers

target

Merck & Co (consumer Health Division)

bidder

Procter & Gamble Company

£2,954m

73 dealmakers

target

BUSCOPAN

bidder

Hypera

£238m

14 dealmakers

target

Terminix Global Holdings

bidder

Rentokil Initial

£5,060m

68 dealmakers

target

Credit Suisse

bidder

Ubs

£2,658m

150 dealmakers

target

SANDOZ

bidder

Institutional Investors

value n/a

43 dealmakers

target

CELLECTIS

bidder

Astrazeneca

£201m

39 dealmakers